The $17 billion Walgreens-Rite Aid deal looks like it's in trouble
Thomson Reuters
Rite Aid's shares are sliding, after a report from the New York Post that supermarket chain Kroger is no longer interested in acquiring 650 stores as part of that deal.
Walgreens and Rite Aid would have to sell the stores in order to gain anti-trust approval for the deal.
The stock is trading around $6.70, well below the $9-per-share price Walgreen's is offering for the company.
According to Bloomberg, that means traders see only an 18% likelihood that the deal will close.
There are other reasons for traders to be concerned: The Federal Trade Commission is likely to find the divestiture package insufficient, Bloomberg reported Wednesday, citing Capital Forum.
The regulator's concerns are related specifically to the pharmacy benefit management, according to the report.
- US-China tariff war could benefit several sectors in India while harming a few others
- Amid heatwave, Delhi's power demand soars to May's highest ever at 7,572 MW
- 84% of Indian small businesses anticipate robust growth in 2024: CPA Australia survey
- Go Digit IPO allotment – How to check allotment, GMP, listing date and more
- 10 breathtaking valleys to visit in India in 2024
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market